10x Genomics, Inc.
TXG
Rang în acțiuni
#2227
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Preț acțiune
$69.74
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$9.09B
Schimbare (1 zi)
-3.67%
Schimbare (1 an)
489.48%
Țară
US
Tranzacționează 10x Genomics, Inc. (TXG)
Categorie
Healthcare
EPS pentru 10x Genomics, Inc. (TXG)
EPS la data de June 2026 TTM: $-0.59
Conform celor mai recente rapoarte financiare și prețului acțiunilor 10x Genomics, Inc., EPS-ul actual al companiei (TTM) este $-0.59. La sfârșitul anului 2024, compania avea un EPS de $-1.52 o scădere comparativ cu EPS-ului din 2023, care a fost de $-2.18.
Istoricul EPS pentru 10x Genomics, Inc. din 2017 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $-0.59 | 68.57% |
| 2025 | $-0.35 | -76.97% |
| 2024 | $-1.52 | -30.28% |
| 2023 | $-2.18 | 49.32% |
| 2022 | $-1.46 | 175.47% |
| 2021 | $-0.53 | -90.13% |
| 2020 | $-5.37 | 571.25% |
| 2019 | $-0.80 | -90.48% |
| 2018 | $-8.40 | 418.52% |
| 2017 | $-1.62 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $3.48 | -689.83% |
US
|
|
| $1.79 | -403.63% |
AU
|
|
| $1.43 | -342.37% |
US
|
|
| $-1.43 | 142.37% |
US
|
|
| - | - |
US
|
